Top compounds associated with response to LIPM


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA YM-155 CTRPv2 pan-cancer AAC -0.14 0.0006
mRNA niclosamide CTRPv2 pan-cancer AAC -0.13 0.001
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.1 0.003
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC 0.16 0.004
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.16 0.004
Download CSV